Just talking potential, repeat potential, risk
factors that might affect Curaegis' minority shareholders. And in relation to the company's convertible note offering. The note, I believe, would not affect an IRC Section 382 ownership change, for instance, since it is not equity, so it wouldn't cause an ultimate 382 limitation. The company is attractive for its NOLs, especially for a guy like Golisano. Just hope everyone does the right thing.